Two years of wearing the Viaskin patch for peanut allergy desensitized 81 percent of peanut-allergic children ages 1 to 3,… Read more »
Tag: viaskin
Viaskin Peanut Patch Desensitized Most Toddlers in Phase 3 Trial
The Viaskin patch for peanut allergy is showing promise in desensitizing peanut-allergic toddlers in a late-stage trial. After wearing the… Read more »
Peanut Patch Therapy Led to Big Quality of Life Improvement for Families
Desensitizing therapies are emerging for food allergies, and being considered for approval by the FDA. But some in the medical… Read more »
Viaskin Peanut Patch Submitted to FDA for Approval Consideration
The manufacturer of the Viaskin Peanut patch has resubmitted its biologics license application (or BLA) to the FDA – in… Read more »
Concerns Raised as ICER Report Praises Peanut Avoidance vs. Therapy
In its final report analyzing the costs and benefits of two novel peanut allergy desensitization products, the Institute for Clinical… Read more »
Peanut Allergy Therapies: ICER’s Review Draws Criticism
What do you get when you undertake a cost-benefit analysis of new therapies when prices have yet to be established… Read more »
Brave Pioneers: The Families in Food Allergy Trials
They’re the courageous food allergy parents and children testing therapies still in the experimental stages.
Peanut Patch Shows Promise For Treatment of Allergy
In trials, Viaskin Peanut allowed some participants to tolerate 10 times more peanut protein than at the outset.